Insys Therapeutics (INSY) Highlights New Clinical Data from Long-Term Safety Study of CBD Oral Solution in Refractory Pediatric Epilepsy
December 4, 2018 6:15 AM
Pharmaceutical-grade cannabidiol (CBD) oral solution made by INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
